These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12243339)

  • 21. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells.
    Pruitt K; Pestell RG; Der CJ
    J Biol Chem; 2000 Dec; 275(52):40916-24. PubMed ID: 11007784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein.
    Peeper DS; Upton TM; Ladha MH; Neuman E; Zalvide J; Bernards R; DeCaprio JA; Ewen ME
    Nature; 1997 Mar; 386(6621):177-81. PubMed ID: 9062190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.
    Garcia-Rendueles ME; Ricarte-Filho JC; Untch BR; Landa I; Knauf JA; Voza F; Smith VE; Ganly I; Taylor BS; Persaud Y; Oler G; Fang Y; Jhanwar SC; Viale A; Heguy A; Huberman KH; Giancotti F; Ghossein R; Fagin JA
    Cancer Discov; 2015 Nov; 5(11):1178-93. PubMed ID: 26359368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
    Kim S; Jho EH
    BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphorylation status of merlin in sporadic vestibular Schwannomas.
    Wang Z; Lu Y; Tang J; Wang H; Wu H
    Mol Cell Biochem; 2009 Apr; 324(1-2):201-6. PubMed ID: 19142715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
    Ye K
    Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.
    Kissil JL; Wilker EW; Johnson KC; Eckman MS; Yaffe MB; Jacks T
    Mol Cell; 2003 Oct; 12(4):841-9. PubMed ID: 14580336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.
    Thaxton C; Lopera J; Bott M; Fernandez-Valle C
    Oncogene; 2008 Apr; 27(19):2705-15. PubMed ID: 17998937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC; Kissil JL; Fry JL; Jacks T
    Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merlin is a negative regulator of human melanoma growth.
    Murray LB; Lau YK; Yu Q
    PLoS One; 2012; 7(8):e43295. PubMed ID: 22912849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.
    Shivakumar L; Minna J; Sakamaki T; Pestell R; White MA
    Mol Cell Biol; 2002 Jun; 22(12):4309-18. PubMed ID: 12024041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensative shuttling of merlin to phosphorylation on serine 518 in vestibular schwannoma.
    Lü J; Zou J; Wu H; Cai L
    Laryngoscope; 2008 Jan; 118(1):169-74. PubMed ID: 17989580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
    Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
    Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
    Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
    Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.
    Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C
    Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.
    Kissil JL; Johnson KC; Eckman MS; Jacks T
    J Biol Chem; 2002 Mar; 277(12):10394-9. PubMed ID: 11782491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
    Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
    Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
    Hikasa H; Sekido Y; Suzuki A
    Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.